CHIMERA: Clustering of Heterogeneous Disease Effects via Distribution Matching of Imaging Patterns
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Many brain disorders and diseases exhibit heterogeneous symptoms and imaging characteristics. This heterogeneity is typically not captured by commonly adopted neuroimaging analyses that seek only a main imaging pattern when two groups need to be differentiated (e.g., patients and controls, or clinical progressors and non-progressors). We propose a novel probabilistic clustering approach, CHIMERA, modeling the pathological process by a combination of multiple regularized transformations from normal/control population to the patient population, thereby seeking to identify multiple imaging patterns that relate to disease effects and to better characterize disease heterogeneity. In our framework, normal and patient populations are considered as point distributions that are matched by a variant of the coherent point drift algorithm. We explain how the posterior probabilities produced during the MAP optimization of CHIMERA can be used for clustering the patients into groups and identifying disease subtypes. CHIMERA was first validated on a synthetic dataset and then on a clinical dataset mixing 317 control subjects and patients suffering from Alzheimer's Disease (AD) and Parkison's Disease (PD). CHIMERA produced better clustering results compared to two standard clustering approaches. We further analyzed 390 T1 MRI scans from Alzheimer's patients. We discovered two main and reproducible AD subtypes displaying significant differences in cognitive performance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cortes, C., & Vapnik, V. (1995) · Machine Learning · doi:10.1007/bf00994018 · Cited by 59,421
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Hubert, L., & Arabie, P. (1985) · Journal of Classification · doi:10.1007/bf01908075 · Cited by 8,219 · cited 4×
“The Adjusted Rand Index was proposed by Hubert and Arabie [35].”
MethodInfluentialA View of the Em Algorithm that Justifies Incremental, Sparse, and other Variants
Neal, R. M., & Hinton, G. E. (1998) · Learning in Graphical Models · doi:10.1007/978-94-011-5014-9_12 · Cited by 2,187 · cited 1×
“The minimization of leads to the minimization of , which is proved in [27].”
BackgroundHonea, R., Crow, T. J., Passingham, D., & Mackay, C. E. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.12.2233 · Cited by 1,157
Dynamics of Gray Matter Loss in Alzheimer's Disease
Thompson, P. M., Hayashi, K. M., de Zubicaray, G., Janke, A. L., Rose, S. E., Semple, J., Herman, D., Hong, M. S., Dittmer, S. S., Doddrell, D. M., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00994.2003 · Cited by 1,132
Murray, M. E., Graff-Radford, N. R., Ross, O. A., Petersen, R. C., Duara, R., & Dickson, D. W. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70156-9 · Cited by 972 · cited 1×
“However, various clinical studies have highlighted the heterogeneity of pathological phenotypes presented by many diseases, such as Alzheimer's disease [9], Schizophrenia [10], Autism spectrum disorder [11], Attention-deficit hyperactivity disorder [12] and Cancer [13], [14].”
BackgroundGlobal and local gray matter loss in mild cognitive impairment and Alzheimer's disease
Karas, G. B., Scheltens, P., Rombouts, S. A. R. B., Visser, P. J., van Schijndel, R. A., Fox, N. C., & Barkhof, F. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.07.006 · Cited by 613
Analysis of a large fMRI cohort: statistical and methodological issues for group analyses
Thirion, B., Pinel, P., Mériaux, S., Roche, A., Dehaene, S., & Poline, J.-B. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.11.054 · Cited by 563 · cited 5×
“We used a dementia clinical dataset of 317 T1 structural MRI scans corresponding to 148 Alzheimer's Disease (AD) patients, 91 Parkinson's Disease (PD) patients and 78 Normal Controls (NC).”
BackgroundInfluentialIdentifying neurocognitive phenotypes in autism
Tager-Flusberg, H., & Joseph, R. M. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2002.1198 · Cited by 460 · cited 1×
“However, various clinical studies have highlighted the heterogeneity of pathological phenotypes presented by many diseases, such as Alzheimer's disease [9], Schizophrenia [10], Autism spectrum disorder [11], Attention-deficit hyperactivity disorder [12] and Cancer [13], [14].”
Background
Cited by
Rathore, S., Habes, M., Iftikhar, M. A., Shacklett, A., & Davatzikos, C. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.03.057 · Cited by 622
Self-citationBiological subtypes of Alzheimer disease: A systematic review and meta-analysis
Ferreira, D., Nordberg, A., & Westman, E. (2020) · Neurology · doi:10.1212/wnl.0000000000009058 · Cited by 422
Disentangling Heterogeneity in Alzheimer’s Disease and Related Dementias Using Data-Driven Methods
Habes, M., Grothe, M. J., Tunc, B., McMillan, C., Wolk, D. A., & Davatzikos, C. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.01.016 · Cited by 167
“, age, sex) in the identification of distinct disease paths differentiating patients from healthy controls was proposed in(43).”
BackgroundSelf-citationA review of neuroimaging-based data-driven approach for Alzheimer’s disease heterogeneity analysis
Liu, L., Sun, S., Kang, W., Wu, S., & Lin, L. (2024) · Reviews in the Neurosciences · doi:10.1515/revneuro-2023-0033 · Cited by 16
“One notable methodology in this area is CHIMERA, which was developed by Dong et al. (2016).”
Method
Metadata
- Authors
- Dong, A., Honnorat, N., Gaonkar, B., & Davatzikos, C.
- Venue
- IEEE Transactions on Medical Imaging
- Published
- 2016-02
- Volume
- 35
- Issue
- 2
- Pages
- 612-621
- ISSN
- 0278-0062 (ISSN-L)
- 1558-254X
- OpenAlex
- W2281357465
- Cited by
- 76
- References
- 11
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.